Orthostatic hypotension and dementia incidence: links and implications

References

• Frewen J, Finucane C, Savva GM, Boyle G, Kenny RA. Orthostatic hypotension is associated with lower cognitive performance in adults aged 50 plus with supine hypertension. J Gerontol Ser A Biol Sci Med Sci. 2014;69(7):878–885. doi:10.1093/gerona/glt17124214492
   PubMed Web of Science ®Google Scholar
• Tilvis RS, Hakala SM, Valvanne J, Erkinjuntti T. Postural hypotension and dizziness in a general aged population: a four-year follow-up of the Helsinki Aging Study. J Am Geriatr Soc. 1996;44(7):809–814.8675929
   PubMed Web of Science ®Google Scholar
• Vloet LC, Pel-Little RE, Jansen PA, Jansen RW. High prevalence of postprandial and orthostatic hypotension among geriatric patients admitted to Dutch hospitals. J Gerontol Ser A Biol Sci Med Sci. 2005;60:1271–1277. doi:10.1093/gerona/60.10.127116282558
   PubMed Web of Science ®Google Scholar
• Rutan GH, Hermanson B, Bild DE, Kittner SJ, LaBaw F, Tell GS. Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Hypertens. 1992;19(6 Pt 1):508–519. doi:10.1161/01.HYP.19.6.508
   PubMed Web of Science ®Google Scholar
• Goldstein DS, Holmes CS, Dendi R, Bruce SR, Li S-T. Orthostatic hypotension from sympathetic denervation in Parkinson’s disease. Neurology. 2002;58(8):1247–1255. doi:10.1212/wnl.58.8.124711971094
   PubMed Web of Science ®Google Scholar
• Tipre DN, Goldstein DS. Cardiac and extracardiac sympathetic denervation in Parkinson’s disease with orthostatic hypotension and in pure autonomic failure. J Nucl Med. 2005;46(11):1775–1781.16269589
   PubMed Web of Science ®Google Scholar
• Velseboer DC, de Haan RJ, Wieling W, Goldstein DS, de Bie RMA. Prevalence of orthostatic hypotension in Parkinson’s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2011;17(10):724–729. doi:10.1016/j.parkreldis.2011.04.01621571570
   PubMed Web of Science ®Google Scholar
• Goldstein DS, Holmes C, Bentho O, et al. Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy. Parkinsonism Relat Disord. 2008;14(8):600–607. doi:10.1016/j.parkreldis.2008.01.01018325818
   PubMed Web of Science ®Google Scholar
• Andersson M, Hansson O, Minthon L, Ballard CG, Londos E. The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies. Int J Geriatr Psychiatry. 2008;23(2):192–198. doi:10.1002/gps.186117621385
   PubMed Web of Science ®Google Scholar
• Antonini A, Barone P, Marconi R, et al. The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life. J Neurol. 2012;259:2621–2631. doi:10.1007/s00415-012-6557-822711157
   PubMed Web of Science ®Google Scholar
• Merola A, Romagnolo A, Rosso M, et al. Autonomic dysfunction in Parkinson’s disease: a prospective cohort study. Mov Disord. 2018;33(3):391–397. doi:10.1002/mds.2726829278286
   PubMed Web of Science ®Google Scholar
• Juraschek SP, Daya N, Appel LJ, et al. Orthostatic hypotension and risk of clinical and subclinical cardiovascular disease in middle‐aged adults. J Am Heart Assoc. 2018;7(10):e008884. doi:10.1161/JAHA.118.00852829735525
   PubMed Web of Science ®Google Scholar
• Milazzo V, Di Stefano C, Milan A, et al. Cardiovascular complications in patients with autonomic failure. Clin Auton Res. 2015;25(3):133–140. doi:10.1007/s10286-015-0275-025791260
   PubMed Web of Science ®Google Scholar
• Angelousi A, Girerd N, Benetos A, et al. Association between orthostatic hypotension and cardiovascular risk, cerebrovascular risk, cognitive decline and falls as well as overall mortality. J Hypertens. 2014;32(8):1562–1571. doi:10.1097/HJH.000000000000023524879490
   PubMed Web of Science ®Google Scholar
• Maule S, Milazzo V, Maule MM, Di Stefano C, Milan A, Veglio F. Mortality and prognosis in patients with neurogenic orthostatic hypotension. Funct Neurol. 2012;27(2):101–106.23158582
   PubMed Web of Science ®Google Scholar
• Iseli R, Nguyen VTV, min S, Reijnierse EM, Lim WK, Maier AB. Orthostatic hypotension and cognition in older adults: a systematic review and meta-analysis. Exp Gerontol. 2019;120:40–49. doi:10.1016/j.exger.2019.02.01730825549
   PubMed Web of Science ®Google Scholar
• Bocti C, Pépin F, Tétreault M, et al. Orthostatic hypotension associated with executive dysfunction in mild cognitive impairment. J Neurol Sci. 2017;382:79–83. doi:10.1016/j.jns.2017.09.02829111025
   PubMed Web of Science ®Google Scholar
• Udow SJ, Robertson AD, MacIntosh BJ, et al. ‘Under pressure’: is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies? J Neurol Neurosurg Psychiatry. 2016;87(12):1311–1321. doi:10.1136/jnnp-2016-31412327613160
   PubMed Web of Science ®Google Scholar
• McDonald C, Newton JL, Burn DJ. Orthostatic hypotension and cognitive impairment in Parkinson’s disease: causation or association? Mov Disord. 2016;31(7):937–946. doi:10.1002/mds.2663227091624
   PubMed Web of Science ®Google Scholar
• Sambati L, Calandra-Buonaura G, Poda R, Guaraldi P, Cortelli P. Orthostatic hypotension and cognitive impairment: a dangerous association? Neurol Sci. 2014;35(6):951–957. doi:10.1007/s10072-014-1686-824590841
   PubMed Web of Science ®Google Scholar
• van Wijnen VK, Finucane C, Harms MPM, et al. Noninvasive beat-to-beat finger arterial pressure monitoring during orthostasis: a comprehensive review of normal and abnormal responses at different ages. J Intern Med. 2017;282(6):468–483. doi:10.1111/joim.1263628564488
   PubMed Web of Science ®Google Scholar
• Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69–72. doi:10.1007/s10286-011-0119-521431947
   PubMed Web of Science ®Google Scholar
• Gibbons CH, Freeman R. Clinical implications of delayed orthostatic hypotension. Neurology. 2015;85(16):1362–1367. doi:10.1212/WNL.000000000000203026400576
   PubMed Web of Science ®Google Scholar
• Elmståhl S, Widerström E. Orthostatic intolerance predicts mild cognitive impairment: incidence of mild cognitive impairment and dementia from the Swedish general population cohort Good Aging in Skåne. Clin Interv Aging. 2014;9:1993. doi:10.2147/CIA.S7231625429211
   PubMed Web of Science ®Google Scholar
• Gibbons CH, Schmidt P, Biaggioni I, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264(8):1567–1582. doi:10.1007/s00415-016-8375-x28050656
   PubMed Web of Science ®Google Scholar
• Jordan J, Shibao C, Biaggioni I. Multiple system atrophy: using clinical pharmacology to reveal pathophysiology. Clin Auton Res. 2015;25(1):53–59. doi:10.1007/s10286-015-0271-425757803
   PubMed Web of Science ®Google Scholar
• Arbogast SD, Alshekhlee A, Hussain Z, McNeeley K, Chelimsky TC. Hypotension unawareness in profound orthostatic hypotension. Am J Med. 2009;122(6):574–580. doi:10.1016/j.amjmed.2008.10.04019486719
   PubMed Web of Science ®Google Scholar
• Palma JA, Gomez-Esteban JC, Norcliffe-Kaufmann L, et al. Orthostatic hypotension in Parkinson disease: how much you fall or how low you go? Mov Disord. 2015;30:639–645. doi:10.1002/mds.2607925678194
   PubMed Web of Science ®Google Scholar
• Merola A, Romagnolo A, Rosso M, et al. Orthostatic hypotension in Parkinson’s disease: does it matter if asymptomatic? Parkinsonism Relat Disord. 2016;33:65–71. doi:10.1016/j.parkreldis.2016.09.01327641792
   PubMed Web of Science ®Google Scholar
• Viramo P, Luukinen H, Koski K, Laippala P, Sulkava R, Kivelä SL. Orthostatic hypotension and cognitive decline in older people. J Am Geriatr Soc. 1999;47(5):600–604.10323655
   PubMed Web of Science ®Google Scholar
• Yap PLK, Niti M, Yap KB, Ng TP. Orthostatic hypotension, hypotension and cognitive status: early comorbid markers of primary dementia? Dement Geriatr Cogn Disord. 2008;26(3):239–246. doi:10.1159/00016095518841007
   PubMed Web of Science ®Google Scholar
• Curreri C, Giantin V, Veronese N, et al. Orthostatic changes in blood pressure and cognitive status in the elderly. Hypertension. 2016;68(2):427–435. doi:10.1161/HYPERTENSIONAHA.116.0733427324223
   PubMed Web of Science ®Google Scholar
• Huang H, Zheng T, Liu F, Wu Z, Liang H, Wang S. Orthostatic hypotension predicts cognitive impairment in the elderly: findings from a cohort study. Front Neurol. 2017;8:121. doi:10.3389/fneur.2017.0012128421033
   PubMed Web of Science ®Google Scholar
• Mitchell AJ. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. J Psychiatr Res. 2009;43(4):411–431. doi:10.1016/j.jpsychires.2008.04.01418579155
   PubMed Web of Science ®Google Scholar
• Kaszás B, Kovács N, Balás I, et al. Sensitivity and specificity of Addenbrooke’s cognitive examination, mattis dementia rating scale, frontal assessment battery and mini mental state examination for diagnosing dementia in Parkinson’s disease. Parkinsonism Relat Disord. 2012;18(5):553–556. doi:10.1016/j.parkreldis.2012.02.01022405839
   PubMed Web of Science ®Google Scholar
• Allcock LM, Kenny RA, Mosimann UP, et al. Orthostatic hypotension in Parkinson’s disease: association with cognitive decline? Int J Geriatr Psychiatry. 2006;21(8):778–783. doi:10.1002/gps.156216906622
   PubMed Web of Science ®Google Scholar
• Robertson AD, Messner MA, Shirzadi Z, et al. Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders. Parkinsonism Relat Disord. 2016;22:80–86. doi:10.1016/j.parkreldis.2015.11.01926639982
   PubMed Web of Science ®Google Scholar
• Feeney J, O’Leary N, Kenny RA. Impaired orthostatic blood pressure recovery and cognitive performance at two-year follow up in older adults: the Irish Longitudinal Study on Ageing. Clin Auton Res. 2016;26(2):127–133. doi:10.1007/s10286-016-0340-326968178
   PubMed Web of Science ®Google Scholar
• Rose KM, Couper D, Eigenbrodt ML, Mosley TH, Sharrett AR, Gottesman RF. Orthostatic hypotension and cognitive function: the Atherosclerosis Risk in Communities Study. Neuroepidemiology. 2010;34(1):1–7. doi:10.1159/00025545919893322
   PubMed Web of Science ®Google Scholar
• Rawlings AM, Juraschek SP, Heiss G, et al. Association of orthostatic hypotension with incident dementia, stroke, and cognitive decline. Neurology. 2018;91(8):e759–e768. doi:10.1212/WNL.000000000000602730045960
   PubMed Web of Science ®Google Scholar
• Wolters FJ, Mattace-Raso FUS, Koudstaal PJ, Hofman A, Ikram MA. Orthostatic hypotension and the long-term risk of dementia: a population-based study. PLoS Med. 2016;13(10):e1002143. doi:10.1371/journal.pmed.100214327727284
   PubMed Web of Science ®Google Scholar
• Cremer A, Soumaré A, Berr C, et al. Orthostatic hypotension and risk of incident dementia. Hypertension. 2017;70(1):44–49. doi:10.1161/HYPERTENSIONAHA.117.0904828559394
   PubMed Web of Science ®Google Scholar
• Holm H, Nägga K, Nilsson ED, et al. Longitudinal and postural changes of blood pressure predict dementia: the Malmö Preventive Project. Eur J Epidemiol. 2017;32(4):327–336. doi:10.1007/s10654-017-0228-028190139
   PubMed Web of Science ®Google Scholar
• Peters R, Anstey KJ, Booth A, et al. Orthostatic hypotension and symptomatic subclinical orthostatic hypotension increase risk of cognitive impairment: an integrated evidence review and analysis of a large older adult hypertensive cohort. Eur Heart J. 2018;39(33):3135–3143. doi:10.1093/eurheartj/ehy41830052878
   PubMed Web of Science ®Google Scholar
• Shaw BH, Garland EM, Black BK, et al. Optimal diagnostic thresholds for diagnosis of orthostatic hypotension with a ‘sit-to-stand test.’. J Hypertens. 2017;35(5):1019–1025. doi:10.1097/HJH.000000000000126528129252
   PubMed Web of Science ®Google Scholar
• Hayakawa T, McGarrigle CA, Coen RF, et al. Orthostatic blood pressure behavior in people with mild cognitive impairment predicts conversion to dementia. J Am Geriatr Soc. 2015;63(9):1868–1873. doi:10.1111/jgs.1359626313614
   PubMed Web of Science ®Google Scholar
• Allan LM, Ballard CG, Allen J, et al. Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatry. 2006;78(7):671–677. doi:10.1136/jnnp.2006.10234317178816
   PubMed Web of Science ®Google Scholar
• Brenowitz WD, Hubbard RA, Keene CD, et al. Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample. Alzheimer’s Dement. 2017;13(6):654–662. doi:10.1016/j.jalz.2016.09.01527870939
   PubMed Web of Science ®Google Scholar
• Postuma RB, Gagnon JF, Pelletier A, Montplaisir J. Prodromal autonomic symptoms and signs in Parkinson’s disease and dementia with Lewy bodies. Mov Disord. 2013;28:597–604. doi:10.1002/mds.2544523554107
   PubMed Web of Science ®Google Scholar
• Anang JB, Gagnon JF, Bertrand JA, et al. Predictors of dementia in Parkinson disease: a prospective cohort study. Neurology. 2014;83:1253–1260. doi:10.1212/WNL.000000000000084225171928
   PubMed Web of Science ®Google Scholar
• Anang JBM, Nomura T, Romenets SR, Nakashima K, Gagnon J-F, Postuma RB. Dementia predictors in Parkinson disease: a validation study. J Parkinsons Dis. 2017;7(1):159–162. doi:10.3233/JPD-16092527911340
   PubMedGoogle Scholar
• Hussain MW, Camicioli R. Nonmotor symptoms of Parkinson’s disease as predictors of dementia. Can J Neurol Sci. 2018;45(1):97–99. doi:10.1017/cjn.2017.23929113606
   PubMed Web of Science ®Google Scholar
• De Pablo-Fernandez E, Tur C, Revesz T, Lees AJ, Holton JL, Warner TT. Association of autonomic dysfunction with disease progression and survival in Parkinson disease. JAMA Neurol. 2017;74(8):970. doi:10.1001/jamaneurol.2017.112528655059
   PubMed Web of Science ®Google Scholar
• Postuma RB, Iranzo A, Hu M, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain. 2019;142(3):744–759. doi:10.1093/brain/awz03030789229
   PubMed Web of Science ®Google Scholar
• Stankovic I, Krismer F, Jesic A, et al. Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group. Mov Disord. 2014;29(7):857–867. doi:10.1002/mds.2588024753321
   PubMed Web of Science ®Google Scholar
• Goldstein DS, Cheshire WP. Roles of cardiac sympathetic neuroimaging in autonomic medicine. Clin Auton Res. 2018;28(4):397–410. doi:10.1007/s10286-018-0547-630062642
   PubMed Web of Science ®Google Scholar
• Choi MH, Yoon JH, Yong SW. Cardiac sympathetic denervation and dementia in de novo Parkinson’s disease: a 7-year follow-up study. J Neurol Sci. 2017;381:291–295. doi:10.1016/j.jns.2017.09.01028991700
   PubMed Web of Science ®Google Scholar
• Haubrich C, Pies K, Dafotakis M, Block F, Kloetzsch C, Diehl RR. Transcranial Doppler monitoring in Parkinson’s disease: cerebrovascular compensation of orthostatic hypotension. Ultrasound Med Biol. 2010;36:1581–1587. doi:10.1016/j.ultrasmedbio.2010.06.01620800957
   PubMed Web of Science ®Google Scholar
• Novak V, Novak P, Spies JM, Low PA. Autoregulation of cerebral blood flow in orthostatic hypotension. Stroke. 1998;29(1):104–111.9445337
   PubMed Web of Science ®Google Scholar
• Tsai SJ, Chen SC, Leu TM, et al. Impairment of cerebral hemodynamic response to the cold pressor test in patients with Parkinson’s disease. Parkinsonism Relat Disord. 2009;15:94–100. doi:10.1016/j.parkreldis.2008.03.00718440850
   PubMed Web of Science ®Google Scholar
• Novak P. Cerebral blood flow, heart rate, and blood pressure patterns during the tilt test in common orthostatic syndromes. Neurosci J. 2016;2016:6127340.27525257
   PubMedGoogle Scholar
• Hayashida K, Nishiooeda Y, Hirose Y, Ishida Y, Nishimura T. Maladaptation of vascular response in frontal area of patients with orthostatic hypotension. J Nucl Med. 1996;37:1–4.8543976
   PubMed Web of Science ®Google Scholar
• van Osch MJP, Jansen PAF, Vingerhoets RW. van der Grond J. Association between supine cerebral perfusion and symptomatic orthostatic hypotension. Neuroimage. 2005;27(4):789–794. doi:10.1016/j.neuroimage.2005.05.02615993626
   PubMed Web of Science ®Google Scholar
• Wolters FJ, Zonneveld HI, Hofman A, et al. Cerebral perfusion and the risk of dementia. Circulation. 2017;136(8):719–728. doi:10.1161/CIRCULATIONAHA.117.02744828588075
   PubMed Web of Science ®Google Scholar
• Williams-Gray CH, Foltynie T, Brayne CEG, Robbins TW, Barker RA. Evolution of cognitive dysfunction in an incident Parkinson’s disease cohort. Brain. 2007;130(7):1787–1798. doi:10.1093/brain/awm11117535834
   PubMed Web of Science ®Google Scholar
• Fanciulli A, Jordan J, Biaggioni I, et al. Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS). Clin Auton Res. 2018;28(4):355–362. doi:10.1007/s10286-018-0529-829766366
   PubMed Web of Science ®Google Scholar
• Fanciulli A, Göbel G, Ndayisaba JP, et al. Supine hypertension in Parkinson’s disease and multiple system atrophy. Clin Auton Res. 2016;26(2):97–105. doi:10.1007/s10286-015-0336-426801189
   PubMed Web of Science ®Google Scholar
• Espay AJ, LeWitt PA, Hauser RA, Merola A, Masellis M, Lang AE. Neurogenic orthostatic hypotension and supine hypertension in Parkinson’s disease and related synucleinopathies: prioritisation of treatment targets. Lancet Neurol. 2016;15(9):954–966. doi:10.1016/S1474-4422(16)30079-527478953
   PubMed Web of Science ®Google Scholar
• Goldstein DS, Pechnik S, Holmes C, Eldadah B, Sharabi Y. Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension. 2003;42(2):136–142. doi:10.1161/01.HYP.0000081216.11623.C312835329
   PubMed Web of Science ®Google Scholar
• Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347(9009):1141–1145. doi:10.1016/s0140-6736(96)90608-x8609748
   PubMed Web of Science ®Google Scholar
• Pilleri M, Facchini S, Gasparoli E, et al. Cognitive and MRI correlates of orthostatic hypotension in Parkinson’s disease. J Neurol. 2013;260(1):253–259. doi:10.1007/s00415-012-6627-y22850936
   PubMed Web of Science ®Google Scholar
• Jordan J, Fanciulli A, Tank J, et al. Management of supine hypertension in patients with neurogenic orthostatic hypotension. J Hypertens. 2019;37(8):1541–1546. doi:10.1097/HJH.000000000000207830882602
   PubMed Web of Science ®Google Scholar
• Ballard C, O’Brien J, Barber B, et al. Neurocardiovascular instability, hypotensive episodes, and MRI lesions in neurodegenerative dementia. Ann N Y Acad Sci. 2000;903:442–445. doi:10.1111/j.1749-6632.2000.tb06396.x10818535
   PubMed Web of Science ®Google Scholar
• Colloby SJ, Vasudev A, O’Brien JT, Firbank MJ, Parry SW, Thomas AJ. Relationship of orthostatic blood pressure to white matter hyperintensities and subcortical volumes in late-life depression. Br J Psychiatry. 2011;199(5):404–410. doi:10.1192/bjp.bp.110.09042321903666
   PubMed Web of Science ®Google Scholar
• Oh YS, Kim JS, Lee KS. Orthostatic and supine blood pressures are associated with white matter hyperintensities in Parkinson disease. J Mov Disord. 2013;6:23–27. doi:10.14802/jmd.1300624868422
   PubMedGoogle Scholar
• Ten Harmsen BL, van Rumund A, Aerts MB, et al. Clinical correlates of cerebral white matter abnormalities in patients with Parkinson’s disease. Parkinsonism Relat Disord. 2018;49:28–33. doi:10.1016/j.parkreldis.2017.12.02929306636
   PubMed Web of Science ®Google Scholar
• Maillard P, Carmichael O, Fletcher E, Reed B, Mungas D, DeCarli C. Coevolution of white matter hyperintensities and cognition in the elderly. Neurology. 2012;79(5):442–448. doi:10.1212/WNL.0b013e318261713622815562
   PubMed Web of Science ®Google Scholar
• Lee S-J, Kim J-S, Yoo J-Y, et al. Influence of white matter hyperintensities on the cognition of patients with Parkinson disease. Alzheimer Dis Assoc Disord. 2010;24(3):227–233. doi:10.1097/WAD.0b013e3181d71a1320473133
   PubMed Web of Science ®Google Scholar
• González-Redondo R, Toledo J, Clavero P, et al. The impact of silent vascular brain burden in cognitive impairment in Parkinson’s disease. Eur J Neurol. 2012;19(8):1100–1107. doi:10.1111/j.1468-1331.2012.03682.x22360775
   PubMed Web of Science ®Google Scholar
• Kim J-S, Oh Y-S, Lee K-S, Kim Y-I, Yang D-W, Goldstein DS. Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease. Neurology. 2012;79(13):1323–1331. doi:10.1212/WNL.0b013e31826c1acd22972639
   PubMed Web of Science ®Google Scholar
• Dadar M, Zeighami Y, Yau Y, et al. White matter hyperintensities are linked to future cognitive decline in de novo Parkinson’s disease patients. NeuroImage Clin. 2018;20:892–900. doi:10.1016/j.nicl.2018.09.02530292088
   PubMed Web of Science ®Google Scholar
• Sunwoo MK, Jeon S, Ham JH, et al. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson’s disease. Eur J Neurol. 2014;21(6):922–e50. doi:10.1111/ene.1241224661277
   PubMed Web of Science ®Google Scholar
• O’Hare C, Kenny R-A, Aizenstein H, et al. Cognitive status, gray matter atrophy, and lower orthostatic blood pressure in older adults. J Alzheimer’s Dis. 2017;57(4):1239–1250. doi:10.3233/JAD-16122828339397
   PubMed Web of Science ®Google Scholar
• Norcliffe-Kaufmann L, Kaufmann H, Palma J-A, et al. Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies. Ann Neurol. 2018;83(3):522–531. doi:10.1002/ana.2517029405350
   PubMed Web of Science ®Google Scholar
• Kehagia AA, Barker RA, Robbins TW. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease. Lancet Neurol. 2010;9(12):1200–1213. doi:10.1016/S1474-4422(10)70212-X20880750
   PubMed Web of Science ®Google Scholar
• Coon EA, Cutsforth-Gregory JK, Benarroch EE. Neuropathology of autonomic dysfunction in synucleinopathies. Mov Disord. 2018;33(3):349–358. doi:10.1002/mds.2718629297596
   PubMed Web of Science ®Google Scholar
• Edvinsson L. Neurogenic mechanisms in the cerebrovascular bed. Autonomic nerves, amine receptors and their effects on cerebral blood flow. Acta Physiol Scand Suppl. 1975;427:1–35.56123
   PubMedGoogle Scholar
• Del Tredici K, Braak H. Sporadic Parkinson’s disease: development and distribution of α-synuclein pathology. Neuropathol Appl Neurobiol. 2016;42(1):33–50. doi:10.1111/nan.1229826662475
   PubMed Web of Science ®Google Scholar
• Espay AJ, Vizcarra JA, Marsili L, et al. Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology. 2019;92(7):329–337. doi:10.1212/WNL.000000000000692630745444
   PubMed Web of Science ®Google Scholar
• Ballard CG, Aarsland D, McKeith I, et al. Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology. 2002;59(11):1714–1720. doi:10.1212/01.wnl.0000036908.39696.fd12473758
   PubMed Web of Science ®Google Scholar
• Escandon A, Al-Hammadi N, Galvin JE. Effect of cognitive fluctuation on neuropsychological performance in aging and dementia. Neurology. 2010;74(3):210–217. doi:10.1212/WNL.0b013e3181ca017d20083796
   PubMed Web of Science ®Google Scholar
• Sun M, Mainland BJ, Ornstein TJ, et al. The association between cognitive fluctuations and activities of daily living and quality of life among institutionalized patients with dementia. Int J Geriatr Psychiatry. 2018;33(2):e280–e285. doi:10.1002/gps.478828940504
   PubMed Web of Science ®Google Scholar
• Centi J, Freeman R, Gibbons CH, Neargarder S, Canova AO, Cronin-Golomb A. Effects of orthostatic hypotension on cognition in Parkinson disease. Neurology. 2017;88(1):17–24. doi:10.1212/WNL.000000000000345227903817
   PubMed Web of Science ®Google Scholar
• Peralta C, Stampfer-Kountchev M, Karner E, et al. Orthostatic hypotension and attention in Parkinson’s disease with and without dementia. J Neural Transm. 2007;114(5):585–588. doi:10.1007/s00702-006-0615-217195917
   PubMed Web of Science ®Google Scholar
• Freidenberg DL, Shaffer LET, Macalester S, Fannin EA. Orthostatic hypotension in patients with dementia. Cogn Behav Neurol. 2013;26(3):105–120. doi:10.1097/WNN.000000000000000324077570
   PubMed Web of Science ®Google Scholar
• Riley DE, Espay AJ. Cognitive fluctuations in Parkinson’s disease dementia: blood pressure lability as an underlying mechanism. J Clin Mov Disord. 2018;5(1):1. doi:10.1186/s40734-018-0068-429456869
   PubMedGoogle Scholar
• Press Y, Punchik B, Freud T. Orthostatic hypotension and drug therapy in patients at an outpatient comprehensive geriatric assessment unit. J Hypertens. 2016;34(2):351–358. doi:10.1097/HJH.000000000000078126599221
   PubMed Web of Science ®Google Scholar
• Redston MR, Hilmer SN, McLachlan AJ, Clough AJ, Gnjidic D. Prevalence of potentially inappropriate medication use in older inpatients with and without cognitive impairment: a systematic review. J Alzheimer’s Dis. 2018;61(4):1639–1652. doi:10.3233/JAD-17084229278890
   PubMed Web of Science ®Google Scholar
• Kujawa K, Leurgans S, Raman R, Blasucci L, Goetz CG. Acute orthostatic hypotension when starting dopamine agonists in Parkinson’s disease. Arch Neurol. 2000;57(10):1461–1463.11030798
   PubMedGoogle Scholar
• Dafsari HS, Martinez‐Martin P, Rizos A, et al. EuroInf 2: subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson’s disease. Mov Disord. 2019;34(3):353–365. doi:10.1002/mds.2762630719763
   PubMed Web of Science ®Google Scholar
• Seppi K, Ray Chaudhuri K, Coelho M, et al. Update on treatments for nonmotor symptoms of Parkinson’s disease-an evidence-based medicine review. Mov Disord. 2019;34(2):180–198. doi:10.1002/mds.2760230653247
   PubMed Web of Science ®Google Scholar
• Bacchi S, Chim I, Kramer P, Postuma RB. Domperidone for hypotension in Parkinson’s disease: a systematic review. J Parkinsons Dis. 2017;7(4):603–617. doi:10.3233/JPD-17120929103053
   PubMedGoogle Scholar
• Xin W, Lin Z, Mi S. Orthostatic hypotension and mortality risk: a meta-analysis of cohort studies. Heart. 2014;100(5):406–413. doi:10.1136/heartjnl-2013-30412123878177
   PubMed Web of Science ®Google Scholar
• Stubendorff K, Aarsland D, Minthon L, Londos E. The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson’s disease with dementia. PLoS One. 2012;7(10):e45451. doi:10.1371/journal.pone.004545123049679
   PubMed Web of Science ®Google Scholar